Pzena Investment Management LLC Sells 16,412 Shares of Cigna Group $CI

Pzena Investment Management LLC trimmed its stake in Cigna Group (NYSE:CI) by 2.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 562,036 shares of the health services provider’s stock after selling 16,412 shares during the period. Pzena Investment Management LLC owned about 0.21% of Cigna Group worth $154,942,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of CI. Wilkerson Advisory Group LLC bought a new position in shares of Cigna Group during the fourth quarter valued at $25,000. Cedar Mountain Advisors LLC grew its holdings in shares of Cigna Group by 161.9% in the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock worth $29,000 after purchasing an additional 68 shares during the last quarter. Kemnay Advisory Services Inc. bought a new stake in shares of Cigna Group in the 4th quarter worth about $29,000. Prosperity Bancshares Inc acquired a new stake in shares of Cigna Group during the 4th quarter worth about $29,000. Finally, ANTIPODES PARTNERS Ltd acquired a new stake in shares of Cigna Group during the 2nd quarter worth about $34,000. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Cigna Group Stock Performance

Shares of NYSE:CI opened at $275.03 on Tuesday. The stock has a market capitalization of $72.67 billion, a P/E ratio of 11.38, a P/E/G ratio of 0.97 and a beta of 0.29. Cigna Group has a 1-year low of $239.51 and a 1-year high of $315.47. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68. The business has a 50-day moving average price of $285.73 and a two-hundred day moving average price of $281.32.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The company had revenue of $70.04 billion for the quarter, compared to analyst estimates of $70.14 billion. During the same quarter last year, the firm earned $7.20 EPS. The company’s revenue for the quarter was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Equities analysts predict that Cigna Group will post 30.51 earnings per share for the current year.

Cigna Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be paid a $1.56 dividend. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. Cigna Group’s dividend payout ratio (DPR) is presently 25.82%.

Insider Buying and Selling

In other news, CAO Jamie G. Kates sold 899 shares of the stock in a transaction on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the transaction, the chief accounting officer owned 2,368 shares of the company’s stock, valued at $707,108.48. This represents a 27.52% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Nicole S. Jones sold 19,436 shares of the firm’s stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total value of $5,369,583.72. Following the completion of the transaction, the insider owned 27,256 shares in the company, valued at $7,530,015.12. This represents a 41.63% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of research firms have commented on CI. The Goldman Sachs Group boosted their price target on shares of Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a research report on Monday, May 4th. Wolfe Research restated an “outperform” rating and issued a $315.00 price objective on shares of Cigna Group in a research report on Tuesday, June 16th. UBS Group boosted their target price on shares of Cigna Group from $375.00 to $400.00 and gave the stock a “buy” rating in a research note on Friday, May 22nd. Mizuho upped their target price on shares of Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a research report on Monday, June 8th. Finally, Robert W. Baird set a $362.00 price objective on shares of Cigna Group in a research report on Friday, July 31st. Fifteen research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat, Cigna Group has a consensus rating of “Moderate Buy” and an average price target of $339.45.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.